Reaction
Post Procedural Haematoma reporting signals
As of the last recalculation, Post Procedural Haematoma appears in 1,675 FAERS reports alongside 25 co-occurring drug terms. The strongest observed disproportionality signal is FONDAPARINUX SODIUM (PRR 93.9).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Fondaparinux Sodium | 59 | 93.9 | 94.5 |
| Cefazolin | 23 | 31.7 | 31.8 |
| Cefazolin Sodium | 26 | 27.2 | 27.3 |
| Rivaroxaban | 314 | 22.8 | 22.9 |
| Enoxaparin Sodium | 72 | 16.2 | 16.2 |
| Acetylcysteine | 12 | 15.9 | 15.9 |
| Prasugrel Hydrochloride | 10 | 12.3 | 12.3 |
| Heparin Sodium | 13 | 11.8 | 11.8 |
| Bupivacaine | 8 | 10.7 | 10.7 |
| Dalteparin Sodium | 9 | 10.6 | 10.6 |
| Clopidogrel Bisulfate | 81 | 10.3 | 10.3 |
| Clopidogrel | 147 | 10.0 | 10.0 |
| Basiliximab | 9 | 9.6 | 9.6 |
| Valganciclovir | 14 | 9.3 | 9.3 |
| Valganciclovir Hydrochloride | 14 | 9.3 | 9.3 |
| Acalabrutinib | 9 | 9.3 | 9.3 |
| Valganciclovir Hydrochloride Powder, | 9 | 9.2 | 9.2 |
| Apixaban | 48 | 9.1 | 9.2 |
| Emicizumab | 9 | 9.1 | 9.1 |
| Ticagrelor | 15 | 5.9 | 5.9 |
| Ibrutinib | 36 | 5.6 | 5.6 |
| Rocuronium Bromide | 5 | 5.3 | 5.3 |
| Dabigatran Etexilate | 29 | 4.7 | 4.7 |
| Dabigatran Etexilate Mesylate | 25 | 4.3 | 4.3 |
| Siponimod | 3 | 4.2 | 4.2 |